SPDR S&P Pharmaceuticals ETF Rating → Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad) Free XPH Stock Alerts $39.52 +0.43 (+1.10%) (As of 04/26/2024 ET) Add Compare Share Share RatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatingsStock AnalysisChartHeadlinesHoldingsOwnershipRatings SPDR S&P Pharmaceuticals ETF Aggregate Rating and Price Target (2024)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.XPH Aggregate RatingModerate Buy2.66Holdings in XPH have an aggregate rating of Moderate Buy based on 293 analyst ratings issued in the past year covering 40 companies (98.9% of the portfolio).XPH Aggregate Price Target$70.3778.06% UpsideHigh Prediction$90.08Average Prediction$70.37Low Prediction$49.00Holdings in XPH have an aggregate price target of $70.37 and a range of $49.00 to $90.08 covering 40 companies (98.9% of the portfolio).XPH Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy17 Buy rating(s)Moderate Buy17 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce0 Reduce rating(s)Sell1 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by SPDR S&P Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 40 XPH Holdings Export to ExcelWeightIn ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings4.81%MRKMerck & Co., Inc.$131.19+0.4%5 of 5 stars2.58$131.33 0.1%12Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage4.79%PRGOPerrigo$31.94+2.1%5 of 5 stars3.00$40.67 27.3%3News Coverage4.74%ITCIIntra-Cellular Therapies$73.26+1.6%4 of 5 stars2.90$90.17 23.1%10Upcoming EarningsAnalyst ReportAnalyst Revision4.74%CTLTCatalent$55.92+0.2%3 of 5 stars2.15$52.46 -6.2%13Analyst ReportNews CoveragePositive News4.69%LLYEli Lilly and Company$733.51+1.2%5 of 5 stars2.84$728.05 -0.7%19Upcoming Earnings4.66%OGNOrganon & Co.$18.55+0.7%5 of 5 stars2.50$21.80 17.6%4Upcoming EarningsNews Coverage4.57%AXSMAxsome Therapeutics$71.71+0.3%4 of 5 stars2.92$119.67 66.9%124.56%PFEPfizer$25.38+0.5%5 of 5 stars2.38$36.33 43.2%16Upcoming EarningsDividend AnnouncementNews Coverage4.55%JAZZJazz Pharmaceuticals$109.46+1.9%5 of 5 stars2.85$195.08 78.2%13Upcoming Earnings4.50%RPRXRoyalty Pharma$28.00-0.4%5 of 5 stars3.00$46.75 67.0%4Positive News4.44%VTRSViatris$11.57+0.9%0 of 5 stars1.33$11.00 -4.9%34.39%JNJJohnson & Johnson$146.13-0.5%5 of 5 stars2.46$175.86 20.3%134.30%BMYBristol-Myers Squibb$44.86+0.4%5 of 5 stars2.11$60.71 35.3%19Earnings ReportAnalyst ReportAnalyst RevisionNews Coverage4.22%ELANElanco Animal Health$13.25+1.6%4 of 5 stars2.57$16.71 26.1%7Short Interest ↑4.21%ZTSZoetis$158.42+3.3%5 of 5 stars3.00$218.00 37.6%7Upcoming EarningsAnalyst Report3.44%CORTCorcept Therapeutics$22.80+2.7%5 of 5 stars3.00$39.30 72.4%4Upcoming EarningsAnalyst Report2.80%ARVNArvinas$32.37+2.4%3 of 5 stars2.88$59.73 84.5%16Upcoming EarningsNews Coverage2.57%EYPTEyePoint Pharmaceuticals$16.75+3.7%3 of 5 stars3.00$34.00 103.0%6Upcoming EarningsPositive News2.42%SAVACassava Sciences$22.34+2.8%3 of 5 stars3.00$124.00 455.1%1News Coverage2.02%AMPHAmphastar Pharmaceuticals$41.11+0.7%5 of 5 stars2.50$66.00 60.5%4Short Interest ↑1.94%TARSTarsus Pharmaceuticals$32.04-0.5%3 of 5 stars2.88$48.38 51.0%81.38%PBHPrestige Consumer Healthcare$70.55+0.6%4 of 5 stars2.50$110.00 55.9%2Analyst RevisionNews Coverage1.24%PCRXPacira BioSciences$26.33+3.3%5 of 5 stars3.00$49.50 88.0%10Upcoming EarningsNews Coverage1.21%LBPHLongboard Pharmaceuticals$19.72+2.4%1 of 5 stars3.00$44.80 127.2%51.21%HRMYHarmony Biosciences$29.32+1.3%4 of 5 stars2.50$40.63 38.6%8Upcoming EarningsPositive News1.17%LQDALiquidia$12.53+1.3%2 of 5 stars2.60$21.00 67.6%5Upcoming Earnings1.13%AMLXAmylyx Pharmaceuticals$1.76-1.1%3 of 5 stars2.25$32.67 1,756.1%8Short Interest ↑Negative News1.09%COLLCollegium Pharmaceutical$36.42+1.6%2 of 5 stars2.60$39.00 7.1%5Analyst UpgradeNews Coverage0.93%SUPNSupernus Pharmaceuticals$30.07+2.6%4 of 5 stars3.00$41.00 36.3%10.89%LGNDLigand Pharmaceuticals$70.57+0.3%5 of 5 stars3.00$116.33 64.8%3Short Interest ↑0.80%AMRXAmneal Pharmaceuticals$5.87-0.5%2 of 5 stars3.00$7.31 24.6%4Upcoming EarningsShort Interest ↑News Coverage0.71%RVNCRevance Therapeutics$3.40+3.3%5 of 5 stars2.50$13.75 304.4%8Short Interest ↓0.67%PLRXPliant Therapeutics$11.81-0.6%3 of 5 stars3.00$49.00 314.9%90.64%ANIPANI Pharmaceuticals$65.36+0.6%4 of 5 stars3.00$80.00 22.4%4Analyst ReportShort Interest ↑0.60%OCULOcular Therapeutix$4.75+12.8%4 of 5 stars3.00$17.60 270.9%5Short Interest ↑0.49%EOLSEvolus$11.43-0.3%4 of 5 stars3.00$20.60 80.2%30.40%XERSXeris Biopharma$1.75+2.9%4 of 5 stars3.00$4.88 178.6%40.36%TBPHTheravance Biopharma$9.12-0.2%1 of 5 stars3.00$20.50 124.8%2Short Interest ↓0.35%MRNSMarinus Pharmaceuticals$1.41-0.7%4 of 5 stars2.57$16.07 1,043.9%7Short Interest ↑0.29%FULCFulcrum Therapeutics$7.14+0.1%2 of 5 stars2.83$13.17 84.4%6Short Interest ↑ This page (NYSEARCA:XPH) was last updated on 4/27/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThe World's First "$20 Trillion Drug?"Behind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SPDR S&P Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
